A single tyrosine of the interleukin-9 (IL-9) receptor is required for STAT activation, antiapoptotic activity, and growth regulation by IL-9
- PMID: 8756628
- PMCID: PMC231471
- DOI: 10.1128/MCB.16.9.4710
A single tyrosine of the interleukin-9 (IL-9) receptor is required for STAT activation, antiapoptotic activity, and growth regulation by IL-9
Abstract
Interleukin-9 (IL-9), a T-cell-derived cytokine, interacts with a specific receptor associated with the IL-2 receptor gamma chain. In this report, we analyze the functional domains of the human IL-9 receptor transfected into mouse lymphoid cell lines. Three different functions were examined: growth stimulation in factor-dependent pro-B Ba/F3 cells, protection against dexamethasone-induced apoptosis, and Ly-6A2 induction in BW5147 lymphoma cells. The results indicated that a single tyrosine, at position 116 in the cytoplasmic domain, was required for all three activities. In addition, we observed that human IL-9 reduced the proliferation rate of transfected BW5147 cells, an effect also dependent on the same tyrosine. This amino acid was necessary for IL-9-mediated tyrosine phosphorylation of the receptor and for STAT activation but not for IRS-2/4PS activation or for JAK1 phosphorylation, which depended on a domain closer to the plasma membrane. We also showed that JAK1 was constitutively associated with the IL-9 receptor. Activated STAT complexes induced by IL-9 were found to contain STAT1, STAT3, and STAT5 transcription factors. Moreover, sequence homologies between human IL-9 receptor tyrosine 116 and tyrosines (of other receptors activating STAT3 and STAT5 were observed. Taken together, these data indicate that a single tyrosine of the IL-9 receptor, required for activation of three different STAT proteins, is necessary for distinct activities of this cytokine, including proliferative responses.
Similar articles
-
Interleukin 9 induces expression of three cytokine signal inhibitors: cytokine-inducible SH2-containing protein, suppressor of cytokine signalling (SOCS)-2 and SOCS-3, but only SOCS-3 overexpression suppresses interleukin 9 signalling.Biochem J. 2001 Jan 1;353(Pt 1):109-116. Biochem J. 2001. PMID: 11115404 Free PMC article.
-
Heteromerization of the gammac chain with the interleukin-9 receptor alpha subunit leads to STAT activation and prevention of apoptosis.J Biol Chem. 1998 Apr 10;273(15):9255-60. doi: 10.1074/jbc.273.15.9255. J Biol Chem. 1998. PMID: 9535918
-
Interleukin-7 signaling in human B cell precursor acute lymphoblastic leukemia cells and murine BAF3 cells involves activation of STAT1 and STAT5 mediated via the interleukin-7 receptor alpha chain.Leukemia. 1996 Aug;10(8):1317-25. Leukemia. 1996. PMID: 8709637
-
Thrombopoietin induces tyrosine phosphorylation of Stat3 and Stat5 in human blood platelets.Blood. 1996 Jan 15;87(2):439-46. Blood. 1996. PMID: 8555464 Review.
-
Stats: transcriptional control and biological impact.Nat Rev Mol Cell Biol. 2002 Sep;3(9):651-62. doi: 10.1038/nrm909. Nat Rev Mol Cell Biol. 2002. PMID: 12209125 Review.
Cited by
-
A fusion cytokine coupling GMCSF to IL9 induces heterologous receptor clustering and STAT1 hyperactivation through JAK2 promiscuity.PLoS One. 2013 Jul 1;8(7):e69405. doi: 10.1371/journal.pone.0069405. Print 2013. PLoS One. 2013. PMID: 23840913 Free PMC article.
-
Interleukin 9 induces expression of three cytokine signal inhibitors: cytokine-inducible SH2-containing protein, suppressor of cytokine signalling (SOCS)-2 and SOCS-3, but only SOCS-3 overexpression suppresses interleukin 9 signalling.Biochem J. 2001 Jan 1;353(Pt 1):109-116. Biochem J. 2001. PMID: 11115404 Free PMC article.
-
Multiple oligomerization domains of KANK1-PDGFRβ are required for JAK2-independent hematopoietic cell proliferation and signaling via STAT5 and ERK.Haematologica. 2011 Oct;96(10):1406-14. doi: 10.3324/haematol.2011.040147. Epub 2011 Jun 17. Haematologica. 2011. PMID: 21685469 Free PMC article.
-
MRG1, the product of a melanocyte-specific gene related gene, is a cytokine-inducible transcription factor with transformation activity.Proc Natl Acad Sci U S A. 1998 Nov 10;95(23):13555-60. doi: 10.1073/pnas.95.23.13555. Proc Natl Acad Sci U S A. 1998. PMID: 9811838 Free PMC article.
-
Neutralization of interleukin-9 ameliorates symptoms of experimental autoimmune myasthenia gravis in rats by decreasing effector T cells and altering humoral responses.Immunology. 2014 Nov;143(3):396-405. doi: 10.1111/imm.12322. Immunology. 2014. PMID: 24850614 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous